| Primary |
| H1n1 Influenza |
28.0% |
| Influenza |
22.9% |
| Sedation |
10.4% |
| Pneumonia |
3.9% |
| Respiratory Distress |
3.9% |
| Infection |
3.6% |
| Prophylaxis |
3.6% |
| Drug Use For Unknown Indication |
3.3% |
| Acute Respiratory Distress Syndrome |
3.0% |
| Asthma |
2.4% |
| Bronchopulmonary Aspergillosis |
1.8% |
| Pneumonia Bacterial |
1.8% |
| Bronchospasm |
1.5% |
| Constipation |
1.5% |
| Nausea |
1.5% |
| Paralysis |
1.5% |
| Sepsis |
1.5% |
| Supplementation Therapy |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Anxiety |
1.2% |
|
| Death |
18.1% |
| Cytolytic Hepatitis |
11.8% |
| Respiratory Failure |
10.2% |
| Encephalopathy |
5.5% |
| Renal Failure |
5.5% |
| Haemoglobin Decreased |
4.7% |
| Acute Respiratory Distress Syndrome |
3.9% |
| Bradycardia |
3.9% |
| Live Birth |
3.9% |
| Sinus Arrest |
3.9% |
| Thrombocytopenia |
3.9% |
| Drug Exposure During Pregnancy |
3.1% |
| Multi-organ Failure |
3.1% |
| Neutropenia |
3.1% |
| Pancytopenia |
3.1% |
| Shock |
3.1% |
| Cardiac Arrest |
2.4% |
| Pneumonia Staphylococcal |
2.4% |
| Pyrexia |
2.4% |
| Abortion Spontaneous |
1.6% |
|
| Secondary |
| H1n1 Influenza |
33.7% |
| Influenza |
32.6% |
| Product Used For Unknown Indication |
13.7% |
| Bronchopulmonary Aspergillosis |
6.3% |
| Immunosuppression |
3.2% |
| Liver Transplant |
3.2% |
| Prophylaxis |
3.2% |
| Gastric Cancer Stage Iii |
2.1% |
| Delirium |
1.1% |
| Pneumonia |
1.1% |
|
| Thrombocytopenia |
15.0% |
| Pancytopenia |
10.0% |
| Haemoglobin Decreased |
7.5% |
| Renal Failure |
7.5% |
| Staphylococcal Bacteraemia |
7.5% |
| Death |
5.0% |
| Linear Iga Disease |
5.0% |
| Multi-organ Failure |
5.0% |
| Pathogen Resistance |
5.0% |
| Pregnancy |
5.0% |
| Respiratory Failure |
5.0% |
| Accidental Overdose |
2.5% |
| Aplasia |
2.5% |
| Blood Creatinine Increased |
2.5% |
| Convulsion |
2.5% |
| Drug Resistance |
2.5% |
| Drug-induced Liver Injury |
2.5% |
| Pneumonia Influenzal |
2.5% |
| Retrograde Portal Vein Flow |
2.5% |
| Tonic Convulsion |
2.5% |
|
| Concomitant |
| Influenza |
22.8% |
| H1n1 Influenza |
15.8% |
| Sepsis |
10.9% |
| Anti-infective Therapy |
7.9% |
| Cardiac Index |
5.9% |
| Antibiotic Therapy |
5.0% |
| Cholecystitis Acute |
4.0% |
| Myocarditis |
3.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.0% |
| Antifungal Prophylaxis |
2.0% |
| Antiviral Treatment |
2.0% |
| Blood Magnesium Decreased |
2.0% |
| Blood Potassium Decreased |
2.0% |
| Eczema |
2.0% |
| Febrile Neutropenia |
2.0% |
| Hypokalaemia |
2.0% |
| Neutropenia |
2.0% |
| Oedema |
2.0% |
| Pain |
2.0% |
| Pathogen Resistance |
2.0% |
|
| Drug Ineffective |
17.2% |
| Staphylococcal Bacteraemia |
13.8% |
| Abortion Spontaneous |
10.3% |
| Thrombotic Microangiopathy |
10.3% |
| Ileus Paralytic |
6.9% |
| Influenza |
6.9% |
| Pathogen Resistance |
6.9% |
| Sepsis |
6.9% |
| Acute Myeloid Leukaemia |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Multi-organ Failure |
3.4% |
| Premature Baby |
3.4% |
| Sepsis Syndrome |
3.4% |
| Subarachnoid Haemorrhage |
3.4% |
|
